Delivering Health and Hope to Nigeria's Poor

by The GEANCO Foundation
Play Video
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor
Delivering Health and Hope to Nigeria's Poor

Project Report | Apr 23, 2019
GEANCO Foundation Updates

By Afam Onyema | Chief Executive Officer

Our Clinton Global Initiative Anemia Program

Our screening of vulnerable women and children for anemia in southeast Nigeria continues on. Anemia is a condition in which not enough healthy red blood cells carry oxygen throughout the body. The poor blood oxygen levels and blood vessel blockages that result lead to chronic, agonizing pain, severe infections, organ failure and potential death. Nigeria has the world's largest anemia-afflicted population - 75% of its children have the condition, and 1 out of every 5 maternal deaths can be traced to anemia.

Testing for anemia is often not performed in Africa because it traditionally has required invasive blood draws and laboratory analysis, which are often not available, or too expensive. This program of non-invasive testing can therefore have a significantly positive impact maternal and child health outcomes.

Through the Clinton Global Initiative, we partner with the medical technology company Masimo Inc. to screen and treat women and children in Nigeria for anemia quickly and painlessly. We have screened over 25,000 women and children in Nigeria. Since we are the only group in Nigeria using Masimo’s advanced, noninvasive technology, it is almost certain that none of these vulnerable Nigerians would have been tested for anemia but for this special program.

We cover the costs of anemia treatment for 300 poor and vulnerable pregnant women in Nigeria each month.

Our Education Program 

On November 16, 2017, we officially opened the "Arinze Ejiofor - Godwin Onyema" Sports Field at Brightland Academy in Enugu, Nigeria. This state-of-the-art field is one of the best in the country, and the school held a special ceremony as GEANCO officers Godwin and Afam Onyema formall inaugrated the field. In May 2018, we added a safety and security fence around the field.

In July 2018, we donated hundreds of soccer jerseys, shorts and socks to Brightland Academy and others in southeast Nigeria. In April 2018, we received 20 laptops from Pfizer, which we again gifted to deserving organizations and institutions in Nigeria. 

In February 2019, we funded and completed construction of a state-of-the-art  basketball-volleyball-tennis court at Brightland. 

David Oyelowo Leadership Scholarship for Girls

Through our David Oyelowo Leadership Scholarship, we cover tuition, room, board, books and supplies, medical care and professional psychological support for young females impacted by Boko Haram and . Five scholars attend the Anglican Girls Grammar School (AGGS) in Abuja, Nigeria’s capital. A secondary school for students aged 10 - 15, AGGS is an academic Center of Excellence known for its strong emphasis on science and math. For girls dealing with instability and insecurity, this all-girls boarding school offers a safe and nurturing learning environment. "Our girls" have had a wonderful experience since they began school in September. They enjoy being back in a safe, supportive learning environment with fellow female students and with teachers and administrators who care deeply for them.

Starting in September 2018, 5 additional girls attend Brigthland as David Oyelowo Leadership Scholars. 

Meet Benedict Cumberbatch & Attend the Avengers®: Endgame Premiere

We ran a special fundraising campaign on Omaze.com offering donors a chance to attend the world premiere of Avengers:Endgame and meet star Benedict Cumberbatch.

Links:

Share on Twitter Share on Facebook

About Project Reports

Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.

Sign up for updates

Organization Information

The GEANCO Foundation

Location: Los Angeles, CA - USA
Website:
Facebook: Facebook Page
X / Twitter: Profile
Project Leader:
Afam Onyema
Los Angeles , CA United States
$10,957 raised of $48,000 goal
 
47 donations
$37,043 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

The GEANCO Foundation has earned this recognition on GlobalGiving:

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Get incredible stories, promotions, and matching offers in your inbox

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.